SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Investors are expressing deep frustration over the token's persistent price stagnation and ongoing dilution, while simultaneously debating the potential impact of future exchange app launches and regulatory shifts on its long-term viability. Sentiment remains polarized, with some community members calling for an exit due to lack of confidence in management, while others continue to accumulate, citing the asset's heavily discounted valuation compared to past highs.

Bakkt, Inc. is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy, spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. Bakkt was founded in 2018 and is headquartered in New York, NY.

Bakkt Inc. - Ordinary Shares - Class A

Bakkt Inc. (BKKT) is experiencing significant downward pressure as investors react to a challenging earnings report and ongoing uncertainty regarding the company's business model transition. While some in the community remain focused on the potential of the new AI-powered infrastructure and institutional partnerships, sentiment is broadly pessimistic, with active discussions dominated by frustration over poor price performance, skepticism toward management's long-term strategy, and concerns over potential further dilution or delisting risks.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is trending due to strong institutional interest and upward momentum, supported by a positive Elliott Wave analysis and recent analyst upgrades that highlight its oncology pipeline as a primary driver for future growth. The company is actively being discussed as a potential major player in oncology M&A, with investors focusing on its strategic acquisition of Firefly Bio and its goal of becoming the world's leading oncology company by 2030.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending as investors weigh strong VEVYE prescription growth against management's recent history of aggressive guidance revisions and the impact of non-recurring gross-to-net adjustments. The community remains focused on the company's platform scalability, upcoming product launches like BYOOVIZ, and long-term potential in the expanding ophthalmic market, despite current price volatility.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is trending as investors monitor a critical minerals roundtable in Washington, D.C., and anticipate upcoming earnings, with the community actively debating whether the company's role as a domestic antimony supplier will trigger a short squeeze. Long-term shareholders remain focused on the company's defense contracts and supply chain integration, while many are closely watching for any government-led policy shifts or major contract announcements to serve as a catalyst for a rebound.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as investors digest a strong earnings report that topped revenue estimates and saw management raise full-year guidance, highlighting robust progress in commercial readiness and infrastructure partnerships. While the company faces pressure from short interest and wider sector volatility, the community is actively debating the significance of its FAA certification milestones, potential military applications, and the long-term viability of the eVTOL market.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals is currently trending due to positive clinical results for its kidney disease drug povetacicept and ongoing investor discussions regarding the company's aggressive expansion beyond its core cystic fibrosis business. The community is actively debating the potential for M&A activity, particularly a possible acquisition of CRISPR Therapeutics, and analyzing the long-term impact of its diversified pipeline on future growth.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce Inc. is seeing significant community debate as traders weigh its valuation and AI-driven growth strategy against recent analyst downgrades. While some investors argue that its embedded enterprise data moats and aggressive buyback programs make it a compelling value play, others remain skeptical about the speed of AI monetization and the impact of sector rotation.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

Canadian Solar is trending as investors digest a shift in leadership and scrutinize the company's U.S. manufacturing expansion, with community discussion heavily focused on the potential impact of 45X tax credits and future battery storage contracts. The stock remains a battleground for retail traders who are actively debating the significance of short interest levels and the valuation disparity compared to other solar manufacturers.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

The VanEck Gold Miners ETF (GDX) is experiencing heightened investor attention as market participants debate whether recent price weakness represents a significant accumulation opportunity or a deeper correction linked to broader macroeconomic instability. The community is actively discussing the impact of persistent inflation, elevated government debt, and central bank physical gold hoarding on the mining sector's long-term outlook.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


Share

Sam